Clinical Trial

Effects of Different Continuous Renal Replacement Therapy Patterns on Ionized Calcium in Patients With Citrate Anticoagulants Using Calcium-containing Replacement Solutions

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 6, 2025 (before its estimated June 9, 2026 completion). Its status may not reflect the trial's current state.
Summary
It is unclear whether different modes of continuous renal replacement therapy (CRRT) impact post-filter ionized calcium concentrations during regional citrate anticoagulation (RCA) when using calcium-containing replacement fluid. This prospective, single-center, observational cohort study will screen all patients receiving CRRT for eligibility. General clinical information will be collected before commencing CRRT treatment. Patients will be randomly assigned to either the veno-venous hemofiltration (CVVH) or continuous veno-venous hemodialysis (CVVHD) group and switch to the alternative mode in the subsequent treatment session. Pre-filter and post-filter ionized calcium, systemic total and ionized calcium, and effluent total and ionized calcium will be measured 2 hours after the initiation of CRRT. Electrolyte levels, arterial blood gases, hourly citrate dose, and total citrate dose will be recorded every 6 hours until the end of CRRT. The primary outcome is the difference in ionized calcium concentrations at each site over time between the two modes.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-08-26; most recent amendment 2025-08-05.
Trial Details
NCT Number NCT06021080
Lead Sponsor Fujian Provincial Hospital
Conditions Renal Injury, Regional Citrate Anticoagulation, Continuous Renal Replacement Therapy
Enrollment 30 participants
Start Date 2023-10-09
Primary Completion 2026-06-09 (estimated)
Study Completion 2026-12-09 (estimated)
Updated on ClinicalTrials.gov 2025-08-06